YTHDF2 and systemic lupus erythematosus: In this study, we found that decreased mRNA expression of YTHDF2 in PBMCs was a risk factor for SLE, suggesting decreased mRNA expression of YTHDF2 may activate MAPK and NF‐κB signaling pathways, which promote the occurrence and development of SLE.